Evoke Pharma (NASDAQ:EVOK) Stock Passes Below Two Hundred Day Moving Average of $0.93

Evoke Pharma, Inc. (NASDAQ:EVOK) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.93 and traded as low as $0.44. Evoke Pharma shares last traded at $0.55, with a volume of 19,055 shares.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Evoke Pharma in a research note on Thursday. They set a “sell” rating on the stock.

Evoke Pharma Price Performance

The business has a 50 day moving average price of $0.63 and a two-hundred day moving average price of $0.93. The stock has a market cap of $4.66 million, a PE ratio of -0.24 and a beta of 0.22.

Evoke Pharma (NASDAQ:EVOK) last released its quarterly earnings data on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share for the quarter. Evoke Pharma had a negative return on equity of 517.99% and a negative net margin of 150.43%. The business had revenue of $1.68 million during the quarter.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.